Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Woster

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
The Biochemical Journal|June 28, 2002
Induction of apoptosis in human leukaemic cells by IPENSpm, a novel polyamine analogue and anti-metaboliteAlison V Fraser, Patrick M Woster, Heather M Wallace
Epigenetics|June 22, 2018
Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesisJoy E Kirkpatrick, Keith L Kirkwood, Patrick M Woster
Amino Acids|March 20, 2013
The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell linesTracy Murray-Stewart, Patrick M Woster, Robert A Casero
The Biochemical Journal|September 29, 2016
Targeting polyamine metabolism for cancer therapy and preventionTracy R Murray-Stewart, Patrick M Woster, Robert A Casero
Proceedings of the Western Pharmacology Society|January 19, 2006
Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analoguesRobert A Casero, Benjamin Frydman, Tracy Murray Stewart, et al.
Essays in Biochemistry|January 26, 2010
Polyamine analogues targeting epigenetic gene regulationYi Huang, Laurence J Marton, Patrick M Woster, et al.
Journal of Cellular and Molecular Medicine|February 10, 2010
A novel histone deacetylase inhibitor prevents IL-1beta induced metabolic dysfunction in pancreatic beta-cellsLaura Susick, Thulani Senanayake, Rajakrishnan Veluthakal, et al.
Biochemical Pharmacology|May 17, 2005
Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytesPiyush M Vyas, Sanjoy Roychowdhury, Patrick M Woster, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2006
Novel alkylpolyaminoguanidines and alkylpolyaminobiguanides with potent antitrypanosomal activityXiangdong Bi, Christina Lopez, Cyrus J Bacchi, et al.
Medchemcomm|January 13, 2015
3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitorsCraig J Kutz, Steven L Holshouser, Ethan A Marrow, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
The Biochemical Journal|June 28, 2002
Induction of apoptosis in human leukaemic cells by IPENSpm, a novel polyamine analogue and anti-metaboliteAlison V Fraser, Patrick M Woster, Heather M Wallace
Epigenetics|June 22, 2018
Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesisJoy E Kirkpatrick, Keith L Kirkwood, Patrick M Woster
Amino Acids|March 20, 2013
The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell linesTracy Murray-Stewart, Patrick M Woster, Robert A Casero
The Biochemical Journal|September 29, 2016
Targeting polyamine metabolism for cancer therapy and preventionTracy R Murray-Stewart, Patrick M Woster, Robert A Casero
Proceedings of the Western Pharmacology Society|January 19, 2006
Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analoguesRobert A Casero, Benjamin Frydman, Tracy Murray Stewart, et al.
Essays in Biochemistry|January 26, 2010
Polyamine analogues targeting epigenetic gene regulationYi Huang, Laurence J Marton, Patrick M Woster, et al.
Journal of Cellular and Molecular Medicine|February 10, 2010
A novel histone deacetylase inhibitor prevents IL-1beta induced metabolic dysfunction in pancreatic beta-cellsLaura Susick, Thulani Senanayake, Rajakrishnan Veluthakal, et al.
Biochemical Pharmacology|May 17, 2005
Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytesPiyush M Vyas, Sanjoy Roychowdhury, Patrick M Woster, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2006
Novel alkylpolyaminoguanidines and alkylpolyaminobiguanides with potent antitrypanosomal activityXiangdong Bi, Christina Lopez, Cyrus J Bacchi, et al.
Medchemcomm|January 13, 2015
3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitorsCraig J Kutz, Steven L Holshouser, Ethan A Marrow, et al.
Pageof 9